For patients with chronic or slow-healing wounds, Persistent Wound Oxygen Therapy offers an innovative and effective alternative to traditional hyperbaric oxygen treatments. One of the most advanced approaches in this field is Vaporous Hyperoxia Therapy (VHT™), a painless and soothing therapy designed to accelerate the wound healing process. Unlike hyperbaric chambers, which require patients to be fully enclosed, VHT™ is applied directly to the affected area, making it a more accessible and comfortable option. The treatment chamber is placed around the wound, where it delivers a gentle, hydrating vapor combined with concentrated oxygen. This oxygen-rich environment is passively absorbed into the tissue, stimulating healing at the cellular level.

Multiple Institutional Review Board (IRB) clinical studies have shown that adding VHT™ to standard wound care can triple healing rates, with an average of 84% of chronic wounds closing within 20 weeks or less. This therapy is particularly beneficial for diabetic foot ulcers, venous leg ulcers, burns, frostbite, and pressure ulcers. VHT™ is typically administered two to three times per week, with each session lasting approximately 40-42 minutes, significantly shorter than traditional Hyperbaric Oxygen Therapy (HBOT), which often requires sessions two to three times longer. The convenience, effectiveness, and non-invasive nature of Persistent Wound Oxygen Therapy make it a promising solution for individuals seeking faster healing and improved wound care outcomes.